• Reliable S-Phase Detection: EdU Imaging Kits (Cy5) in Practi

  2026-06-11

  This article presents expert, scenario-driven guidance on overcoming cell proliferation and genotoxicity assay challenges using EdU Imaging Kits (Cy5) (SKU K1076). From practical protocol optimization to vendor selection, we explore how this 5-ethynyl-2'-deoxyuridine imaging kit delivers high sensitivity, workflow safety, and reproducibility for fluorescence microscopy and flow cytometry applications.

• CFDA SE Cell Tracer Kit: Practical Guidance for Stable Cell

  2026-06-10

  The CFDA SE (carboxyfluorescein diacetate succinimidyl ester) Cell Tracer Kit provides robust, long-term fluorescent labeling for cell proliferation and lineage tracing workflows. It should be used where stable, covalent cell tagging is required, but is not suitable for reversible or short-term cell labeling applications.

• TBK1 Inhibition Alleviates Painful Diabetic Neuropathy via M

  2026-06-10

  The reference study reveals that TANK-binding kinase 1 (TBK1) activation drives painful diabetic neuropathy (PDN) by promoting microglial pyroptosis in the spinal dorsal horn. Inhibiting TBK1, either genetically or pharmacologically, suppresses this neuroinflammatory pathway, offering new translational targets for PDN management.

• Natural Deletion of TaASN-B2 Lowers Grain Asparagine in Whea

  2026-06-09

  Oddy et al. (2021) reveal that wheat varieties lacking the TaASN-B2 gene produce grains with reduced free asparagine, a precursor of harmful acrylamide in processed foods. This genetic insight provides breeders with a practical target for improving wheat quality and food safety.

• Propranolol: Applied Workflows for Cardiovascular and Memory

  2026-06-09

  Propranolol’s unique non-selective β-adrenergic receptor blockade enables rigorous cardiovascular regulation, emotional memory modulation, and essential tremor workflows. This article delivers stepwise protocol guidance, troubleshooting insights, and evidence-based optimization strategies, making APExBIO’s Propranolol indispensable for translational research.

• Eicosapentaenoic Acid: EPA Omega-3 Fatty Acid in Cardiovascu

  2026-06-08

  Eicosapentaenoic Acid (EPA) stands out as an advanced omega-3 fatty acid for cardiovascular and immunometabolic assays, offering reproducible inhibition of endothelial cell migration and lipid oxidation. Rigorous workflows supported by APExBIO’s high-purity EPA enable precise, quantitative studies of lipid-lowering and anti-inflammatory mechanisms at the bench.

• Optimizing S-Phase DNA Synthesis with EdU Imaging Kits (Cy5)

  2026-06-08

  EdU Imaging Kits (Cy5) address the need for sensitive, high-specificity detection of cell proliferation via direct measurement of S-phase DNA synthesis, eliminating harsh denaturation steps inherent to BrdU-based assays. This kit is best suited for fluorescence microscopy and flow cytometry in basic and translational research, but is not intended for in vivo or tissue-level applications without further validation.

• YTHDF1 LLPS Drives SSC-to-Neural Fate via IkB-NF-κB-CCND1 Ax

  2026-06-07

  Fang et al. demonstrate that YTHDF1-mediated liquid-liquid phase separation (LLPS) is essential for the direct conversion of spermatogonial stem cells (SSCs) to neural stem cell-like cells. This process operates by repressing IkBa/b mRNA translation, thereby activating the IkB-NF-κB-CCND1 axis, revealing a new regulatory layer in cell fate transitions.

• Cycloastragenol Inhibits Osteoclast Activity in Steroid-Indu

  2026-06-06

  This study demonstrates that cycloastragenol (CAG) significantly reduces bone loss by inhibiting osteoclast activity in a glucocorticoid-induced osteonecrosis of the femoral head (GIONFH) rat model. The findings provide mechanistic insight, highlighting CAG’s potential as a hip-preserving therapeutic agent for GIONFH.

• Translating PLC Inhibition: U-73122 in Cancer Invasion Resea

  2026-06-05

  Explore how U-73122, a potent phospholipase C inhibitor, empowers translational researchers to dissect and modulate PLC-driven cancer invasiveness. This article bridges mechanistic insight with strategic experimental guidance, spotlighting protocol parameters, data interpretation, and translational implications for breast cancer and inflammation models.

• Differential Volatile Mechanisms of Chuanxiong in Coronary D

  2026-06-05

  This article examines the innovative network pharmacology and metabolomics approach used to distinguish the volatile bioactive profiles of Chuanxiong cortex and pith in coronary heart disease models. The study reveals distinct molecular targets and pathways for each tissue, with 1-Phenyl-1-pentanol (Fenipentol) highlighted as a key cortex constituent, informing future research on cardiovascular and gastrointestinal modulation.

• Modeling Breast Cancer Relapse with Proliferation Tracing in

  2026-06-04

  This study presents a dual recombinase genetic system in the MMTV-PyMT mouse model to trace and ablate proliferating tumor cells, providing new insights into breast cancer relapse. Single-cell RNA sequencing revealed increased cancer stem cell populations and immune remodeling in relapsed tumors, offering a robust preclinical platform for studying recurrence mechanisms and evaluating therapeutic strategies.

• Atrial Natriuretic Peptide: Protocols & Troubleshooting in C

  2026-06-04

  Discover how Atrial Natriuretic Peptide (ANP) enables precision studies of blood pressure, natriuresis, and metabolic modulation in rat models. This guide delivers advanced protocol design, troubleshooting, and workflow enhancements to maximize the impact of APExBIO’s high-purity cardiovascular research peptide.

• IR-820 (New Indocyanine Green): Next-Gen In Vivo Imaging Wor

  2026-06-03

  IR-820 (New Indocyanine Green) sets the standard for near-infrared in vivo imaging, enabling precise vascular and tumor tissue quantification in live models. Learn how optimized protocols and nanoplatform innovations maximize signal, reproducibility, and research impact.

• Triacetin Digestion and Metabolic Effects: New Insights from

  2026-06-03

  This study elucidates the complete digestion and absorption pathway of triacetin—a short-chain triacylglycerol—in rats, demonstrating its conversion to acetic acid and glycerol in the upper gastrointestinal tract. The findings reveal that metabolites of triacetin modulate key hepatic genes and AMPK activation, highlighting a dual role as both energy substrate and metabolic signaling molecule.

451 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page